Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL4459692

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
Cc1ccc(C)c2oc(-c3nc(-c4ccc(C(=O)O)cc4)no3)cc12

Basic Information

ChEMBL ID CHEMBL4459692
Phase Preclinical
Structure Type MOL
InChI Key AVCXUODHLRZJJP-UHFFFAOYSA-N
6
Targets
7
Activities
1
Assay Types
9
PK Parameters
16
Publications
0
Known Names

Molecular Properties

334.3
MW (Da)
4.46
ALogP
5
HBA
1
HBD
89.4
PSA (Ų)
0.59
QED
0
Ro5 Violations
3
Rot. Bonds

Drug Information

Molecule Type Unknown
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C19H14N2O4
MW 334.33
Aromatic Rings 4
Heavy Atoms 25
NP-Likeness -0.88

Activity Summary

EC50 7 meas. best 8.72

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Retinoic acid receptor beta
CHEMBL3266
EC50 8.72 8.72 1.9 1
Retinoic acid receptor beta
CHEMBL2008
EC50 8.71 8.7 1.9 2
Retinoic acid receptor gamma
CHEMBL2003
EC50 7.96 7.96 11.0 1
Retinoic acid receptor gamma
CHEMBL4177
EC50 7.89 7.89 13.0 1
Retinoic acid receptor alpha
CHEMBL2055
EC50 7.58 7.58 26.0 1
Retinoic acid receptor alpha
CHEMBL2792
EC50 7.58 7.58 26.0 1

Pharmacokinetic Data

Parameter Value Units Species
CL 1.0 uL/min Homo sapiens
CL 0.06167 mL.min-1.kg-1 Rattus norvegicus
CL 0.01833 mL.min-1.kg-1 Canis lupus familiaris
F 40.0 % Rattus norvegicus
F 40.0 % Canis lupus familiaris
T1/2 1.4 hr Rattus norvegicus
T1/2 2.5 hr Canis lupus familiaris
Tmax 1.7 hr Rattus norvegicus
Tmax 1.0 hr Canis lupus familiaris

Activity Data Samples

Top measurements by pChEMBL value

Literature References

PubMed DOI Target Context # Activities
30792038 10.1016/j.bmcl.2019.02.011 ADMET 23
30792038 10.1016/j.bmcl.2019.02.011 Unchecked 5
30792038 10.1016/j.bmcl.2019.02.011 Salmonella typhimurium 3
30792038 10.1016/j.bmcl.2019.02.011 Retinoic acid receptor beta 2
30792038 10.1016/j.bmcl.2019.02.011 Rattus norvegicus 2
30792038 10.1016/j.bmcl.2019.02.011 CHO-K1 2
30792038 10.1016/j.bmcl.2019.02.011 Retinoic acid receptor alpha 1
30792038 10.1016/j.bmcl.2019.02.011 Retinoic acid receptor gamma 1
30792038 10.1016/j.bmcl.2019.02.011 No relevant target 1
30792038 10.1016/j.bmcl.2019.02.011 Cytochrome P450 1A2 1
30792038 10.1016/j.bmcl.2019.02.011 Cytochrome P450 2C9 1
30792038 10.1016/j.bmcl.2019.02.011 Cytochrome P450 2C19 1
30792038 10.1016/j.bmcl.2019.02.011 Cytochrome P450 2D6 1
30792038 10.1016/j.bmcl.2019.02.011 Cytochrome P450 3A4 1
30792038 10.1016/j.bmcl.2019.02.011 HepG2 1
30792038 10.1016/j.bmcl.2019.02.011 Voltage-gated inwardly rectifying potassium channel KCNH2 1

Data from ChEMBL 36 via Core Engine